LyondellBasell Industries N.V.
For the period ended Mar 31, 2026. Filed May 1, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 1, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Segment and Related Information
- Segment and Related Information
Our operations are managed by senior executives who report to our Chief Executive Officer, the chief operating decision maker. Discrete financial information is available for each of the segments. The Chief Executive Officer uses EBITDA as the primary measure for reviewing the profitability of our segments and allocating resources to the segments. We define EBITDA as net income before interest, income taxes, and depreciation and amortization. Our chief operating decision maker does not receive information about total assets by reportable segment.
The activities of each of our segments from which they earn revenues and incur expenses are described below:
Olefins and Polyolefins-Americas (“O&P-Americas”). Our O&P-Americas segment produces and markets olefins and co-products, polyethylene and polypropylene.
Olefins and Polyolefins-Europe, Asia, International (“O&P-EAI”). Our O&P-EAI segment produces and markets olefins and co-products, polyethylene and polypropylene.
Intermediates and Derivatives (“I&D”). Our I&D segment produces and markets propylene oxide and its derivatives; oxyfuels and related products; and intermediate chemicals such as styrene monomer and acetyls.
Advanced Polymer Solutions (“APS”). Our APS segment produces and markets compounding and solutions, such as polypropylene compounds, engineered plastics, masterbatches, engineered composites, and colors.
Technology. Our Technology segment develops and licenses chemical and polyolefin process technologies and manufactures and sells polyolefin catalysts.
“Other” includes intersegment eliminations and items that are not directly related or allocated to business operations, such as foreign exchange gains or losses and components of pension and other postretirement benefit costs other than service costs. Sales between segments are made at prices approximating prevailing market prices.
Summarized financial information concerning reportable segments is shown in the following tables for the periods presented:
| Three Months Ended March 31, 2026 | |||||||
|---|---|---|---|---|---|---|---|
| Millions of dollars | O&P–Americas | O&P–EAI | I&D | APS | Technology | Other | Total |
| Sales and other operating revenues: | |||||||
| Customers | $1,920 | $2,300 | $2,023 | $873 | $81 | $— | $7,197 |
| Intersegment | 517 | 201 | 37 | 3 | 25 | (783) | — |
| 2,437 | 2,501 | 2,060 | 876 | 106 | (783) | 7,197 | |
| Less: | |||||||
| Cost of sales | 2,179 | 2,431 | 1,861 | 750 | 60 | (785) | 6,496 |
| Impairments | — | 15 | — | — | — | — | 15 |
| (Income) loss from equity investments | (9) | 15 | (1) | — | — | — | 5 |
| Other items | 104 | 118 | 80 | 88 | 39 | 8 | 437 |
| Add: | |||||||
| Depreciation and amortization expense | 164 | 43 | 104 | 20 | 11 | — | 342 |
| EBITDA | $327 | $(35) | $224 | $58 | $18 | $(6) | $586 |
| Capital expenditures | $120 | $61 | $58 | $17 | $13 | $— | $269 |
| Three Months Ended March 31, 2025 | |||||||
|---|---|---|---|---|---|---|---|
| Millions of dollars | O&P–Americas | O&P–EAI | I&D | APS | Technology | Other | Total |
| Sales and other operating revenues: | |||||||
| Customers | $1,957 | $2,435 | $2,282 | $904 | $99 | $— | $7,677 |
| Intersegment | 524 | 165 | 16 | 4 | 21 | (730) | — |
| 2,481 | 2,600 | 2,298 | 908 | 120 | (730) | 7,677 | |
| Less: | |||||||
| Cost of sales | 2,273 | 2,510 | 2,233 | 800 | 44 | (732) | 7,128 |
| (Income) loss from equity investments | (7) | 6 | — | — | — | — | (1) |
| Other items | 119 | 106 | 70 | 82 | 34 | 3 | 414 |
| Add: | |||||||
| Depreciation and amortization expense | 155 | 39 | 99 | 20 | 10 | — | 323 |
| EBITDA | $251 | $17 | $94 | $46 | $52 | $(1) | $459 |
| Capital expenditures | $216 | $124 | $91 | $30 | $22 | $— | $483 |
Other items include Selling, general and administrative (“SG&A”) expenses, Research and development expenses, and Other income, net.
A reconciliation of EBITDA to Income from continuing operations before income taxes is shown in the following table for each of the periods presented:
| Three Months EndedMarch 31, | ||
|---|---|---|
| Millions of dollars | 2026 | 2025 |
| EBITDA: | ||
| Total segment EBITDA | $592 | $460 |
| Other EBITDA | (6) | (1) |
| Less: | ||
| Depreciation and amortization expense | (342) | (323) |
| Interest expense | (138) | (107) |
| Add: | ||
| Interest income | 31 | 30 |
| Income from continuing operations before income taxes | $137 | $59 |
Closure of European PO Joint Venture—In March 2025, we announced the permanent closure of our European PO Joint Venture. During the three months ended March 31, 2025, we recognized $117 million of costs associated with the closure which are reflected in Cost of sales in the Consolidated Statements of Income.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.